Compare VNDA & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNDA | CVGW |
|---|---|---|
| Founded | 2002 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.3M | 479.9M |
| IPO Year | 2005 | 2002 |
| Metric | VNDA | CVGW |
|---|---|---|
| Price | $6.00 | $26.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $14.90 | ★ $33.50 |
| AVG Volume (30 Days) | ★ 1.1M | 311.3K |
| Earning Date | 05-06-2026 | 06-08-2026 |
| Dividend Yield | N/A | ★ 2.85% |
| EPS Growth | N/A | ★ 1950.00 |
| EPS | N/A | ★ 0.04 |
| Revenue | $216,105,000.00 | ★ $648,434,000.00 |
| Revenue This Year | $21.35 | N/A |
| Revenue Next Year | $37.40 | N/A |
| P/E Ratio | ★ N/A | $671.50 |
| Revenue Growth | ★ 8.72 | N/A |
| 52 Week Low | $4.14 | $18.40 |
| 52 Week High | $9.91 | $28.98 |
| Indicator | VNDA | CVGW |
|---|---|---|
| Relative Strength Index (RSI) | 33.15 | 41.72 |
| Support Level | $5.73 | $26.50 |
| Resistance Level | $7.76 | $26.86 |
| Average True Range (ATR) | 0.30 | 0.43 |
| MACD | -0.07 | -0.20 |
| Stochastic Oscillator | 2.83 | 9.09 |
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.